Long-Term Impact of Vutrisiran in Patients With TTR Amyloidosis With Cardiomyopathy: 1-Year Efficacy and Safety Outcomes From the HELIOS-B Open-Label Extension

Pablo Garcia-Pavia, Ronald Witteles, Caroline Morbach, Diego Delgado, Hiroaki Kitaoka, Mathew S. Maurer, Peter van der Meer, Ali Yilmaz, Vincent Algalarrondo, Scott D. Solomon, Francesco Cappelli, Olga Azevedo, W.H. Wilson Tang, Olivier Lairez, Katherine L. Boyle, Satish A. Eraly, Yinggu Bao, Shaun Bender, John Vest, Marianna Fontana

Open source

DOI: 10.1161/circulationaha.126.080735
Published: 2026-11-03
Container: Circulation
Publisher: Ovid Technologies (Wolters Kluwer Health)
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1161/circulationaha.126.080735,
  title = {Long-Term Impact of Vutrisiran in Patients With TTR Amyloidosis With Cardiomyopathy: 1-Year Efficacy and Safety Outcomes From the HELIOS-B Open-Label Extension},
  author = {Pablo Garcia-Pavia and Ronald Witteles and Caroline Morbach and Diego Delgado and Hiroaki Kitaoka and Mathew S. Maurer and Peter van der Meer and Ali Yilmaz and Vincent Algalarrondo and Scott D. Solomon and Francesco Cappelli and Olga Azevedo and W.H. Wilson Tang and Olivier Lairez and Katherine L. Boyle and Satish A. Eraly and Yinggu Bao and Shaun Bender and John Vest and Marianna Fontana},
  year = {2026},
  journal = {Circulation},
  doi = {10.1161/circulationaha.126.080735},
  url = {https://doi.org/10.1161/circulationaha.126.080735}
}

RIS

TY  - JOUR
TI  - Long-Term Impact of Vutrisiran in Patients With TTR Amyloidosis With Cardiomyopathy: 1-Year Efficacy and Safety Outcomes From the HELIOS-B Open-Label Extension
AU  - Pablo Garcia-Pavia
AU  - Ronald Witteles
AU  - Caroline Morbach
AU  - Diego Delgado
AU  - Hiroaki Kitaoka
AU  - Mathew S. Maurer
AU  - Peter van der Meer
AU  - Ali Yilmaz
AU  - Vincent Algalarrondo
AU  - Scott D. Solomon
AU  - Francesco Cappelli
AU  - Olga Azevedo
AU  - W.H. Wilson Tang
AU  - Olivier Lairez
AU  - Katherine L. Boyle
AU  - Satish A. Eraly
AU  - Yinggu Bao
AU  - Shaun Bender
AU  - John Vest
AU  - Marianna Fontana
PY  - 2026
JO  - Circulation
DO  - 10.1161/circulationaha.126.080735
UR  - https://doi.org/10.1161/circulationaha.126.080735
ER  -

APA

Garcia-Pavia, P., Witteles, R., Morbach, C., Delgado, D., Kitaoka, H., Maurer, M. S., Meer, P. V. D., Yilmaz, A., Algalarrondo, V., Solomon, S. D., Cappelli, F., Azevedo, O., Tang, W. W., Lairez, O., Boyle, K. L., Eraly, S. A., Bao, Y., Bender, S., Vest, J., & Fontana, M. (2026). Long-Term Impact of Vutrisiran in Patients With TTR Amyloidosis With Cardiomyopathy: 1-Year Efficacy and Safety Outcomes From the HELIOS-B Open-Label Extension. Circulation. https://doi.org/10.1161/circulationaha.126.080735

Source records

crossref · retrieved 2026-11-04T19:17:58.801Z